News

Filter

Current filters:

ustekinumab

1 to 9 of 19 results

Janssen-Cilag's Stelara backed by UK’s NICE for moderate-to-severe plaque psoriasis

23-09-2009

Janssen-Cilag, a Johnson & Johnson company, says that its Stelara (ustekinumab) has today been approved…

BiotechnologyEnbreletanerceptEuropeJanssen-CilagJohnson & JohnsonStelara Injectionustekinumab

FDA extends review time for J&J's Stelara by three months

27-05-2009

The US Food and Drug Administration has extended by three months the review timeline for the Biologic…

Johnson & JohnsonStelara Injectionustekinumab

FDA further delays J&J's psoriasis drug Stelara, requests more information

12-01-2009

The US Food and Drug Administration has announced further delays for US health care major Johnson & Johnson…

AmgenEnbreletanerceptinfliximabJanssen-CilagJohnson & JohnsonRemicadeSchering PloughSchering-PloughStelara InjectionustekinumabWyeth

1 to 9 of 19 results

COMPANY SPOTLIGHT

Menarini

Back to top